0001114220-17-000028.txt : 20170913
0001114220-17-000028.hdr.sgml : 20170913
20170913205734
ACCESSION NUMBER: 0001114220-17-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170911
FILED AS OF DATE: 20170913
DATE AS OF CHANGE: 20170913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Enyedy Mark J
CENTRAL INDEX KEY: 0001586965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 171084392
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-466-3500
MAIL ADDRESS:
STREET 1: ONE MARINA PARK DR.
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
wf-form4_150535063941262.xml
FORM 4
X0306
4
2017-09-11
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001586965
Enyedy Mark J
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
1
0
0
0
Stock Options (right to buy)
7.32
2017-09-11
4
A
0
50000
7.32
A
2018-09-11
2027-09-11
Common Stock
50000.0
50000
D
The 50,000 stock options vest as follows: 16,667 on September 11, 2018; 16,667 on September 11, 2019; 16,666 on September 11, 2020.
/s/ Brian Adams, Attorney-in-Fact
2017-09-13